Amedeo Smart

Free Medical Literature Service

 

Amedeo

Vaccines
  Free Subscription

Articles published in
Arch Virol
    April 2024
  1. ALVAREZ-QUINTO R, Grinstead S, Kinard G, Martin R, et al
    Complete genome sequence of vaccinium-associated virus C, a new member of the family Totiviridae from Vaccinium floribundum.
    Arch Virol. 2024;169:86.
    >> Share

    March 2024
  2. LATIFI T, Kachooei A, Jalilvand S, Zafarian S, et al
    Correlates of immune protection against human rotaviruses: natural infection and vaccination.
    Arch Virol. 2024;169:72.
    >> Share

    February 2024
  3. TAFFAREL AI, Barrios Benito MY, Hung VV, Cardillo S, et al
    Foot-and-mouth disease virus strains isolated in Vietnam during 2010-2019: genetic characterization and antigenic relatedness to the Euro SA vaccine.
    Arch Virol. 2024;169:44.
    >> Share

    January 2024
  4. SPRYGIN A, van Schalkwyk A, Mazloum A, Byadovskaya O, et al
    Genome sequence characterization of the unique recombinant vaccine-like lumpy skin disease virus strain Kurgan/2018.
    Arch Virol. 2024;169:23.
    >> Share

  5. MACEDO LFR, Ribeiro EC, Wanzala EJ, Neto OCS, et al
    Pentavalent and poliomyelitis vaccines: a review of the vaccination coverage in Brazilian children in the last 10 years.
    Arch Virol. 2024;169:17.
    >> Share

    November 2023
  6. ABDUL-KAREEM HH, Al-Maqtoofi MY, Burghal AA
    Impact of COVID-19 vaccination on saliva immune barriers: IgA, lysozyme, and lactoferrin.
    Arch Virol. 2023;168:293.
    >> Share

    September 2023
  7. MESEKO C, Ameji NO, Kumar B, Culhane M, et al
    Rational approach to vaccination against highly pathogenic avian influenza in Nigeria: a scientific perspective and global best practice.
    Arch Virol. 2023;168:263.
    >> Share

    August 2023
  8. GNEZDILOVA LA, Laga VY, Marzanova SN, Pozyabin SV, et al
    Evidence of insufficient genetic data and lack of regular genetic research on rabies virus in the Russian Federation: a study of the recent epizootic situation.
    Arch Virol. 2023;168:219.
    >> Share

    July 2023
  9. REN X, Zeng Z, Shang Y, Yao L, et al
    C-terminal truncation of the hemagglutinin-neuraminidase (HN) protein enhances the virulence and immunogenicity of Newcastle disease virus (NDV) vaccine strain V4.
    Arch Virol. 2023;168:203.
    >> Share

  10. LENG M, Bian X, Chen Y, Liang Z, et al
    The attenuated live vaccine strain W2512 provides protection against novel variant infectious bursal disease virus.
    Arch Virol. 2023;168:200.
    >> Share

    June 2023
  11. BHANOTHU V, Munne K, Pande S, Singh P, et al
    The dynamics of SARS-CoV-2 infection in unvaccinated and vaccinated populations in Mumbai, India, between 28 December 2020 and 30 August 2021.
    Arch Virol. 2023;168:188.
    >> Share

  12. GWYNN A, Mbewana S, Lubisi BA, Tshabalala HM, et al
    Chimaeric plant-produced bluetongue virus particles as potential vaccine candidates.
    Arch Virol. 2023;168:179.
    >> Share

  13. AMIT LN, John JL, Mori D, Chin AZ, et al
    Increase in rotavirus prevalence with the emergence of genotype G9P[8] in replacement of genotype G12P[6] in Sabah, Malaysia.
    Arch Virol. 2023;168:173.
    >> Share

    May 2023
  14. ZHANG Y, Wang J, Xie Y, Cao X, et al
    Epidemiological characteristics of patients from fever clinics during the COVID-19 epidemic in 2022 in Shanghai, China.
    Arch Virol. 2023;168:164.
    >> Share

    April 2023
  15. TUSHABE P, Bwogi J, Eliku JP, Aine F, et al
    Environmental surveillance detects circulating vaccine-derived poliovirus type 2 that was undetected by acute flaccid paralysis surveillance in 2021 in Uganda.
    Arch Virol. 2023;168:140.
    >> Share

    March 2023
  16. MARTINS M, do Nascimento GM, Conforti A, Noll JCG, et al
    A linear SARS-CoV-2 DNA vaccine candidate reduces virus shedding in ferrets.
    Arch Virol. 2023;168:124.
    >> Share

    February 2023
  17. NEMOTO M, Reedy SE, Yano T, Suzuki K, et al
    Antigenic comparison of H3N8 equine influenza viruses belonging to Florida sublineage clade 1 between vaccine strains and North American strains isolated in 2021-2022.
    Arch Virol. 2023;168:94.
    >> Share

    January 2023
  18. BAZID AH, Amer HM, Nayel M, Attia M, et al
    Assessment of the potency and effectiveness of a heptavalent oil-adjuvanted (ISA 206) foot-and-mouth disease vaccine in Egypt.
    Arch Virol. 2023;168:62.
    >> Share

  19. HUANG Y, Xu H, Liu S, Lu J, et al
    Accidental acquisition of a rescued Japanese encephalitis virus with unspliced introns in the viral genome when using an intron-based stabilization approach.
    Arch Virol. 2023;168:60.
    >> Share

  20. KATSURA M, Fukushima M, Kameyama KI, Kokuho T, et al
    Novel bovine viral diarrhea virus (BVDV) virus-like particle vaccine candidates presenting the E2 protein using the SpyTag/SpyCatcher system induce a robust neutralizing antibody response in mice.
    Arch Virol. 2023;168:49.
    >> Share

  21. BANNAI H, Kambayashi Y, Nemoto M, Ohta M, et al
    Experimental challenge of horses after prime-boost immunization with a modified live equid alphaherpesvirus 1 vaccine administered by two different routes.
    Arch Virol. 2023;168:27.
    >> Share

    November 2022
  22. GRACHEVA AV, Korchevaya ER, Ammour YI, Smirnova DI, et al
    Immunogenic properties of SARS-CoV-2 inactivated by ultraviolet light.
    Arch Virol. 2022;167:2181-2191.
    >> Share

    September 2022
  23. LI ZX, Feng S, Zhang H, Zhuang XY, et al
    Immunogenicity and protective efficacy of a DNA vaccine inducing optimal expression of the SARS-CoV-2 S gene in hACE2 mice.
    Arch Virol. 2022 Sep 9. pii: 10.1007/s00705-022-05562.
    >> Share

  24. PONNUSAMY P, Sukumar K, Raja A, Saravanan S, et al
    Characterization of infectious laryngotracheitis virus isolates from laying hens during 2019-2020 outbreaks in Tamil Nadu, India.
    Arch Virol. 2022;167:1819-1829.
    >> Share

    July 2022
  25. JUNG JS, Lee R, Yoon SI, Lee GS, et al
    Genetic and immunological characterization of commercial infectious bronchitis virus vaccines used in Korea.
    Arch Virol. 2022 Jul 11. pii: 10.1007/s00705-022-05519.
    >> Share

  26. DOAN HTT, Do RT, Thao PTP, Le XTK, et al
    Molecular genotypic analysis of porcine circovirus type 2 reveals the predominance of PCV2d in Vietnam (2018-2020) and the association between PCV2h, the recombinant forms, and Vietnamese vaccines.
    Arch Virol. 2022 Jul 6. pii: 10.1007/s00705-022-05517.
    >> Share

    June 2022
  27. BHANUPRAKASH V, Hosamani M, Venkatesan G, Singh RK, et al
    Long-term protective immunity to goatpox in goats after a single immunization with a live attenuated goatpox vaccine.
    Arch Virol. 2022 Jun 26. pii: 10.1007/s00705-022-05505.
    >> Share

  28. DAHER-NASHIF S, Al-Anany R, Ali M, Erradi K, et al
    COVID-19 exit strategy during vaccine implementation: a balance between social distancing and herd immunity.
    Arch Virol. 2022 Jun 20. pii: 10.1007/s00705-022-05495.
    >> Share

    May 2022
  29. PIERI M, Nicolai E, Nuccetelli M, Sarubbi S, et al
    Validation of a quantitative lateral flow immunoassay (LFIA)-based point-of-care (POC) rapid test for SARS-CoV-2 neutralizing antibodies.
    Arch Virol. 2022;167:1285-1291.
    >> Share

    April 2022
  30. BIN UMAIR M, Akusa FN, Kashif H, Seerat-E-Fatima, et al
    Viruses as tools in gene therapy, vaccine development, and cancer treatment.
    Arch Virol. 2022 Apr 24. pii: 10.1007/s00705-022-05432.
    >> Share

    February 2022
  31. OZ ME, Torlak E
    A high-resolution melting assay to differentiate a peste des petits ruminants virus vaccine strain from field isolates in Turkey.
    Arch Virol. 2022 Feb 11. pii: 10.1007/s00705-022-05386.
    >> Share

  32. ZHOU J, Li C, Tang A, Li H, et al
    Immunogenicity of an inactivated novel goose parvovirus vaccine for short beak and dwarfism syndrome in Cherry Valley ducks.
    Arch Virol. 2022 Feb 11. pii: 10.1007/s00705-021-05352.
    >> Share

  33. LI H, Ge Z, Luo Q, Fu Q, et al
    A highly pathogenic Marek's disease virus isolate from chickens immunized with a bivalent vaccine in China.
    Arch Virol. 2022 Feb 7. pii: 10.1007/s00705-021-05355.
    >> Share

    January 2022
  34. COKCALISKAN C, Tuncer-Goktuna P, Sareyyupoglu B, Turkoglu T, et al
    Booster administration can make a difference in the antibody response to intradermal foot-and-mouth disease vaccination in cattle.
    Arch Virol. 2022 Jan 16. pii: 10.1007/s00705-021-05273.
    >> Share

    December 2021
  35. ZHAO W, Zhang P, Bai S, Lv M, et al
    Heterologous prime-boost regimens with HAdV-5 and NDV vectors elicit stronger immune responses to Ebola virus than homologous regimens in mice.
    Arch Virol. 2021;166:3333-3341.
    >> Share

    October 2021
  36. JANG Y, Seo SH
    H5 cleavage-site peptide vaccine protects chickens from lethal infection by highly pathogenic H5 avian influenza viruses.
    Arch Virol. 2021 Oct 25. pii: 10.1007/s00705-021-05284.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016